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p262 14
orical variables were expressed in median and interquartile
ange. Chi square was used when applied. P value <0.05 was
onsidered signiﬁcative.
Results: 351 HIV patients were assisted during the period.
edian age was 32 YO (27—39). 73.5% male and 26.5%
emale. Median SAPS II 35 (29—43). 186 (54%) were on MV.
ength of stay was 6 days (3—11). 162 patients (46.2%)
ied. Considering patients on MV, SAPS II was 41 (34—51),
ength of stay in ICU was 6 days (2—10) and 143 died
76.9%) VAP ocurred as a complication in 43 (23%) patients
n MV, median SAPS II was 36 (31—42), length of stay 12
ays (9—17), 39/43 died (90.7%) 35 (89.7%) of whom died
n septic shock Etiology: Acinetobacter 17, Pseudomona
eruginosa 14, Methicillin-sensitve Staphylococcus aureus 4,
ethicillin-resistant Staphylococcus aureus 4 and Klebsiella
p 4. 143 patients (77%) on MV did not develop VAP, SAPS
I was 43 (36—54), length of stay in ICU 4 days (2—8), 104
72.7%) died. Patients on MV who developed VAP were less
ll at admission (SAPS II 36 vs 43 p < 0.001) length of stay was
onger (12 vs 4 p < 0.001 and mortality was higher (39/43 vs
04/143 OR 3.66 [CI 1.15—12.9]).
Conclusion: Although HIV-infected patients VAP incidence
nd etiology is similar to that of the HIV-non infected
atients, its overwhelming evolution to multiorgan failure
ndmuch highermortality almost always represents the ﬁnal
vent in the clinical evolution of this group of ICU patients.
oi:10.1016/j.ijid.2010.02.2068
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Background: Central line associated bacteremia (CLAB) is
ssociated with an increased length of stay of up to 6 days
t the intensive care unit (ICU), with an attributable mor-
ality of 35% approximately. The reduction in the incidence
f Methicillin-resistant staphylococcus aureus (MRSA) cen-
ral line associated bloodstream Infections continues being
challenge according to the last tendencies published by the
DC in the (ICU) of the United States. S. aureus is the most
recuent pathogen causing blood stream infections in Latin
merica (SENTRY 1996-2006). The prevalence of nosocomial
. aureus oxacillin resistant is 46% in Argentina. The purpose
f this study was to decrease CLAB at the ICU, particulary
RSA (most prevalent pathogen of CLAB in our institution).
Methods: Data was collected from September 1, 2007 to
uly 1, 2009, on all ICU patients who had central venous
atheter placed at the Clínica y Maternidad Suizo Argentina.
fter one year of baseline data collection the infection con-
rol team implemented a set of measures for the insertion
f CVC (bundle): antiseptic handwashing, maximal barrier
recaution, skin preparation with chlorhexidine 2% instead
f iodopovidone solution, use of gown mask and cap for
he assistant and avoidance of femoral lines. The staff
f physician and nurses was educated on bloodstream-
i
s
pternational Congress on Infectious Diseases (ICID) Abstracts
nfection-control practices before the new elements were
dded to the protocol. A check list form was ﬁlled out by
n ICU nurse manager after each central line placement.
he NHSN criteria for CLAB were met. The data were col-
ected by an infection control nurse. The rates of CLAB were
alculated with Excel and Epi 5 Control Argentina program.
Results: During the pre-intervention period the rate of
LAB was 9,47 ‰ (1900 CVC lineday) and decreased to 3,62
post-intervention (1934 CVC line-day). The rate of gram
ositive CLAB also decreased from 6,84 ‰ (IC. 0.31%-0.15%)
o 1,55 ‰ (IC. 0,02%—0,33%). P: < 0,022.This decreasing ten-
ency was also observed in relation to the MRSA(5 ‰ versus
,09 ‰).
Conclusion: The use of central line bundle and to mon-
tor its adherence with a central line insertion check list,
igniﬁcantly reduced the rate of CLAB.
oi:10.1016/j.ijid.2010.02.2069
6.031
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Background: An increased number of cases of C. difﬁcile
ssociated disease (CDAD) has been observed, associated
ith the emergence of a particular strain, NAP1/BI/027. The
bjective of this prospective study was to characterise C.
ifﬁcile isolates in a referral hospital.
Methods: From 6/1/2008 to 9/30/2009 all stool samples
ent to the clinical microbiology laboratory for C. difﬁcile
oxin A/B detection were processed by a commercial EIA and
ulture. A further RT-PCR for detection of TcdC was done
n all positive samples for either toxin or culture; in each
solate multiplex-PCR was performed to detect TcdA/TcdB
nd CdtA/CdtB genes, and all isolates were ribotyped. Clin-
cal data was recorded from patients with a positive result.
DAD was diagnosed when the microbiology data supported
he clinical ﬁndings.
Results: A total of 1093 samples were screened for toxin
/B and culture; 6.2% were positive by toxin A/B detec-
ion (68/1093), 8.32% (91/1093) by culture, and 10.52%
115/1093) by any of them. Out of the 115 cases, 13 were
xcluded. From the 102 remaining patients, only 85 (83%)
ad CDAD; 25 (29.5%) had severe CDAD; 55 received oral
etronidazole: 89% cured, 7.3% relapsed, and 11% failed.
rom 64 isolates from CDAD patients: 45.3% had a negative
oxin A/B, 89% a positive TcdA/TcdB, and 87.5% had a posi-
ive TcdC; 35.7% revealed the characteristic 18 pb deletion
n TcdC, and 10 patients had severe disease (40% vs 16%,
< 0.02). From 55 ribotyped isolates, 49 (89%) were groupedn 11 clusters, none similar to the 027 ribotype. From 20
evere CDAD isolates analysed, 3 showed the 18 bp deletion,
ositive CdtA/CdtB genes and quinolone resistance.
